209 related articles for article (PubMed ID: 8843288)
1. In vitro and in vivo activities of LB10522, a new catecholic cephalosporin.
Kim MY; Oh JI; Paek KS; Kim YZ; Kim IC; Kwak JH
Antimicrob Agents Chemother; 1996 Aug; 40(8):1825-31. PubMed ID: 8843288
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
3. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
Inoue K; Inoue E; Mitsuhashi S
Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum.
Watanabe N; Hiruma R; Katsu K
Antimicrob Agents Chemother; 1992 Mar; 36(3):589-97. PubMed ID: 1622167
[TBL] [Abstract][Full Text] [Related]
5. The antimicrobial activity and beta-lactamase stability of cefpirome, a new fourth-generation cephalosporin in comparison with other agents.
Cheng AF; Ling TK; Lam AW; Fung KS; Wise R
J Antimicrob Chemother; 1993 May; 31(5):699-709. PubMed ID: 8335498
[TBL] [Abstract][Full Text] [Related]
6. The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa.
Neu HC; Chin NX; Labthavikul P
Infection; 1985; 13(3):146-55. PubMed ID: 3928497
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
Chin NX; Gu JW; Fang W; Neu HC
Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of Ro 09-1428 compared to other cephalosporins.
Chin NX; Gu JW; Fang W; Neu HC
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):669-75. PubMed ID: 1748124
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.
Klein O; Chin NX; Huang HB; Neu HC
Antimicrob Agents Chemother; 1994 Dec; 38(12):2896-901. PubMed ID: 7695279
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
11. In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.
Fujimoto T; Watanabe M; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1990 Sep; 26(3):329-41. PubMed ID: 2228824
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study.
Karlowsky JA; Adam HJ; Baxter MR; Lagacé-Wiens PR; Walkty AJ; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2013 Nov; 57(11):5600-11. PubMed ID: 23979759
[TBL] [Abstract][Full Text] [Related]
13. In-vitro and in-vivo antibacterial activity of LB10517, a novel catechol-substituted cephalosporin with a broad antibacterial spectrum.
Song HK; Oh JI; Kim MY; Kim YZ; Kim IC; Kwak JH
J Antimicrob Chemother; 1996 Apr; 37(4):711-26. PubMed ID: 8722537
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity and beta-lactamase stability of LJC 10,627.
Neu HC; Gu JW; Fang W; Chin NX
Antimicrob Agents Chemother; 1992 Jul; 36(7):1418-23. PubMed ID: 1510436
[TBL] [Abstract][Full Text] [Related]
16. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
Pillar CM; Aranza MK; Shah D; Sahm DF
J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
Neu HC
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activity of the new semisynthetic cephalosporin cefpirome.
Mitsukude M; Inoue M; Mitsuhashi S
Arzneimittelforschung; 1989 Jan; 39(1):26-30. PubMed ID: 2785801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
